Snapshot
Thalassemia and Sickle Cell Society (TSCS)
SECTOR: Health
SUB SECTOR: Medical services
% Spent on beneficiaries
84%
Financial Score:
Age: 21 Years
Tax Benefit: 50%
Foreign donations:
Location(s): Telangana
Issues Addressed:
Promote appropriate treatment and quality life for Thalassemia and Sickle cell anemia affected
Supported by:
Telangana State Government; Asha Jyothi Foundation; Jindal Aluminium Pvt. Ltd.; Sun Pharma Laboratories Ltd.; Aztec Consulting; AIMS Asia
Key Trustees:
Ms. K. Ratnavalli; Dr. Suman Jain; Mr. Chandrakant Agarwal; Mr. Manoj Rupani
Sector Comparison:
Beneficiary Spend:
Average: 79.6% Highest: 99.9% Lowest: 28.7%
Income:
Average: Rs6 cr Highest: Rs115 cr Lowest: Rs1 lac
How much to donate
  • Rs6,500/month for supporting 1 Thalassemia affected child.
  • Rs33,000 for 1 Portable Infusion Pump for a poor patient.
Donate
See our recommended NGOs
Journey of saving Lives of the Thalassemia affected
  • Crisis: In India, there are 35 million Thalassemia gene carriers and 10-12,000 infants are born every year with major Haemoglobinopathies. Thalassemia patients need costly medicines and safe blood transfusion every 2-3 weeks.
  • TSCS has a Transfusion Center, Blood Bank and Diagnostic Center, equipped with the latest facilities and offering free safe blood transfusions, medical and genetic counselling, periodic checkups and medicines at subsidized rates.
  • Outcome: 1) Annually, Transfusion Center helps around 2,000 patients (3 months to >20 year olds). 2) 50% of the patients are children <10 years old, thus there is scope for permanent cure. 3) Blood Bank provides 10-12,000 units yearly.
  • Future Plan: Bone Marrow Transplant (cost >Rs1.5 million/patient) is the only permanent cure for Thalassemia. TSCS is establishing BMT units to enhance the outcome and reduce cost.
Income
Rs
8 cr
Expense
Rs
5 cr
Source : Audit Report 2017